From: Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study
Controls | Case | Total | |||
---|---|---|---|---|---|
n (%) | n (%) | n (%) | p value | ||
T | 1 | 19 (21.6) | 5 (21.7) | 24 (21.6) | 1.000 |
2 | 28 (31.8) | 7 (30.4) | 35 (31.5) | ||
3 | 24 (27.3) | 6 (26.1) | 30 (27.0) | ||
4 | 17 (19.3) | 5 (21.7) | 22 (19.8) | ||
Total | 89 (100) | 23 (100) | 111 (100) | ||
N | 0 | 10 (11.4) | 3 (13.0) | 13 (11.7) | 0.069 |
1 | 23 (26.1) | 2 (8.7) | 25 (22.5) | ||
2A | 25 (28.4) | 4 (17.4) | 29 (26.1) | ||
2B | 15 (17.0) | 10 (43.5) | 25 (22.5) | ||
2C/3 | 15 (17.0) | 4 (17.4) | 19 (17.1) | ||
Total | 89 (100) | 23 (100) | 111 (100) | ||
Sex | male | 66 (75.0) | 19 (82.0) | 85 (76.6) | 0.584 |
female | 22 (25.0) | 4 (17.4) | 26. (23.4) | ||
Total | 88 (100) | 23 (100) | 111 (100) | ||
Hb conc | <140 | 37 (49.3) | 14 (66.7) | 51 (53.1) | 0.217 |
>140 | 38 (50.7) | 7 (33.3) | 45 (46.9) | ||
Total | 75 (100) | 21 (100) | 96 (100) | ||
PS Karnofsky | <90 | 6 (7.2) | 3 (13) | 9 (8.5) | 0.465 |
>90 | 77 (92,8) | 20 (87) | 97 (91.5) | ||
Total | 83 (100) | 23 (100) | 106 (100) | ||
HPV-status (>70 % p16+) | + | 28 (82.4) | 6 (75.0) | 34 (81.0) | 0.635 |
- | 6 (17.6) | 2 (25.0) | 8 (19.0) | ||
Total | 34 (100) | 8 (100) | 42 (100) |